CLDF Title
Contact Us | Bookmark
HBV HE HCC HCV
About CLDF Centers of Educational Expertise  
Live CME Meetings Telewebs Webcasts Slide Library Abstract Library Conference Highlights
Featured Programs
HCV News Tonight   Banner2   EASL 2015   IC-Hep
 
             
  Liver News - REUTERS   Congress Calendar   Physician Resources  
 
 
New oral medication inhibits hepatitis D viral replication
07-29-2015
Elevated LFTS in celiac disease often normalize with gluten-free diet
07-28-2015
AbbVie gets FDA approval for Hep C combination therapy
07-24-2015
Evidence lacking for tests for psoriasis patients using biologic agents
07-23-2015
View Complete News Library
 
 
September 4-6
9th Annual ILCA (INTERNATIONAL LIVER CANCER ASSOCIATION) Conference
Paris, France
September 25-26
GALA Chicago Congress 2015
Chicago, IL
September 26-27
Gut Microbiome Conference 2015
Huntington Beach, CA
October 16-21
ACG 2015 Annual Scientific Meeting and Postgraduate Course
Honolulu, Hawaii
View all Congresses
 
HighwayRx
 
 
 
  Line  
  Featured Abstracts          
 
Revolutionizing treatment outcomes in hepatitis C: managed care implications and considerations-diagnosis and management
 
Efficacy and Safety of Ombitasvir, Paritaprevir, and Ritonavir in an Open-label Study of Patients With Genotype 1b Chronic Hepatitis C Virus, With and Without Cirrhosis
 
Revolutionizing treatment outcomes in hepatitis c: managed care implications and considerations-the new and evolving standards of care
 
Revolutionizing treatment outcomes in hepatitis c: managed care implications and considerations-a clinical overview
 
Increase in nonhepatic diagnoses among persons with hepatitis C hospitalized for any cause, United States, 2004-2011
 
Treating Fibrosing Cholestatic Hepatitis C with Sofosbuvir and Ribavirin: A Matched Analysis
 
 
Present and future therapies of hepatitis B: From discovery to cure
 
Randomized Controlled Trial of Entecavir Versus Placebo in Children with HBeAg-positive Chronic Hepatitis B
 
Comparison of Accelerated and Standard Hepatitis B Vaccination Schedules in High-Risk Healthy Adults: A Meta-Analysis of Randomized Controlled Trials
 
A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: 2015 Update
 
Diabetes as a risk factor for hepatic encephalopathy in cirrhosis patients
 
New Methods of Testing and Brain Imaging in Hepatic Encephalopathy: A Review
 
 
Varices and Variceal Hemorrhage in Cirrhosis. A new view of an old problem
 
The Clinical Relevance of Minimal Hepatic Encephalopathy - A Critical Look
 
Association of Non-alcoholic Fatty Liver Disease (NAFLD) with Hepatocellular Carcinoma (HCC) in the United States from 2004-2009
 
Systematic Review of Single Large and/or Multinodular Hepatocellular Carcinoma: Surgical Resection Improves Survival
 
Hepatic Re-resection Versus Transarterial Chemoembolization for the Treatment of Recurrent Hepatocellular Carcinoma after Initial Resection: a Systematic Review and Meta-analysis
 
Hepatocellular Carcinoma in the Absence of Cirrhosis in US Veterans is Associated with Non-Alcoholic Fatty Liver Disease
 
 
          View All Abstracts  
  Line  
                 
 
HBV
Webcasts
Slide Library
Abstract Library
 
HE
Webcasts
Slide Library
Abstract Library
 
HCC
Slide Library
Abstract Library
 
 
HCV
Live CME Meetings
Telewebs
Webcasts
Slide Library
Abstract Library
 
CLDF Follow Us
   
 
About CLDF
Mission Statement
Board of Trustees
Board of Advisors
CLDF Supporters
 
Other Resources
Liver News Library
Journal Abstracts
Hep C Link to Care
 
Centers of
Educational Expertise
Regional Map
     
   
  The Chronic Liver Disease Foundation is a non-profit organization with content developed specifically for healthcare professionals.
© Copyright 2012-2015 Chronic Liver Disease Foundation. All rights reserved. This site is maintained as an educational resource for US healthcare providers only.
Use of this Web site is governed by the Chronic Liver Disease Foundation terms of use and privacy statement.